Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Figure 5

Fagan’s nomogram of circulating miRNAs (a) and microRNA-122 (b) for diagnosing nonalcoholic fatty liver disease.

(a)

(b)